)
Visual
test
Syncona
Syncona (SYNC) investor relations material
Syncona Q3 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 TU earnings summary5 Feb, 2026
Executive summary
Achieved positive NAV performance with a 3.6% NAV per share return for the quarter ended 31 December 2025, driven by Beacon's valuation uplift and Autolus' share price appreciation.
Portfolio is well-positioned for multiple key value inflection points, with improving biotech market conditions supporting future growth.
Financial highlights
Net assets increased to £1,058.2 million (173.9p per share) from £1,020.9 million (167.9p per share) as of 30 September 2025.
Life Science Portfolio valued at £840.1 million, up from £750.2 million, delivering a 5.0% return in the quarter.
Over nine months, NAV per share returned 1.8% and the Life Science Portfolio generated a 3.3% return.
Capital pool stood at £218.1 million at 31 December 2025, with £52.6 million deployed in the quarter.
Outlook and guidance
Eight key value inflection points expected over the next three years, with four anticipated in calendar year 2026 from commercial and late-stage clinical companies.
Portfolio is funded to deliver on these milestones, with potential for significant NAV growth through M&A and liquidity events.
Quell's key milestone delayed to 2027 due to strategic reprioritization, focusing on a larger commercial opportunity.
Rationale for Quell's QEL-005 prioritization
Details on recent new portfolio investments
Impact of biotech market recovery on portfolio
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Syncona
- NAV up 1.2% to GBP 1.2bn, portfolio 71% clinical stage, and GBP 60m buyback supports growth.SYNC
H2 20243 Feb 2026 - NAV fell 5.2% as late-stage portfolio advanced, with FDA approval and capital inflows supporting growth.SYNCH1 202514 Jan 2026
- NAV fell (1.7)% to £1,020.9m; five value inflection points and £250m return targeted.SYNCH1 202626 Nov 2025
- NAV per share down 9.5% to 170.9p, portfolio 78.5% clinical, strategic plan for cash returns.SYNCH2 202525 Nov 2025
- NAV per share rose 0.5% as clinical and strategic milestones drove portfolio growth.SYNCQ1 2026 TU1 Sep 2025
- Portfolio value declined as quoted holdings fell, but clinical-stage assets and capital inflows grew.SYNCQ1 2025 TU13 Jun 2025
- Q3 saw stable NAV, key clinical milestones, and disciplined capital deployment despite market headwinds.SYNCQ3 2025 TU6 Jun 2025
Next Syncona earnings date
Q4 202618 Jun, 2026
Syncona
Next Syncona earnings date
Q4 202618 Jun, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage